Huibin Song

Dr. Huibin Song


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YCYingtong Chen
Yingtong Chen
XLXiaohan Li
Xiaohan Li
FZFuhua Zhong
Fuhua Zhong
XWXiaoya Wang
Xiaoya Wang
QWQiang Wang
Qiang Wang
CLChen Lin
Chen Lin
Aims and objectives: Retinoblastoma is the most common pediatric intraocular malignancy, although it remains a rare disease overall, yet the molecular targets and therapeutic vulnerabilities sustaining its most aggressive proliferative cell states remain incompletely defined. We aimed to identify actionable molecular regulators and potential therapeutic targets of malignant retinoblastoma progression using integrated single-cell transcriptomics and functional validation. Methods: We analyzed single-cell RNA sequencing data from 189,431 cells derived from 13 retinoblastoma tumors and 3 normal fetal retina samples. Data integration was performed using Harmony, followed by clustering, differential expression, and functional enrichment analyses. BIRC5 function was evaluated through overexpression and siRNA-mediated knockdown in retinoblastoma cell lines (Y79, WERI-Rb1), with assessment of proliferation, migration, invasion, and cell cycle–related proteins. Results: Clustering identified 10 retinal cell types, including cone precursor-like, cone-like, and two MKI67 + proliferative RB subpopulations enrichment of G2/M-phase genes and chromosomal instability pathways. MKI67 + cells2 displayed hyperactivated cell cycle genes, chromosomal instability, and mitotic checkpoint dysregulation. BIRC5 (survivin) was selectively overexpressed in 93.7% of MKI67 + cells2 (mean expression 1.733 ± 0.643), while minimally expressed in other retinal cells. Functional assays demonstrated that BIRC5 overexpression promoted proliferation, invasion, migration, and CCND1/CDK4 activation, while suppressing CHEK2–p21–mediated checkpoint control. Conversely, BIRC5 knockdown induced G1 cell cycle arrest and increased apoptotic activity, accompanied by activation of checkpoint pathways. Conclusion: This study defines BIRC5 as a cell-state–specific regulator of malignant proliferation in retinoblastoma and provides a mechanistic rationale for targeting survivin in highly proliferative tumor subpopulations.

27 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
JMJie Mao
Jie Mao
JXjinquan xia
jinquan xia
HSHuibin Song
Huibin Song
FZFuhua Zhong
Fuhua Zhong
HFHuiyi Feng
Huiyi Feng
GWGuangsuo Wang
Guangsuo Wang
Background: Tumor invasion is the central barrier to effective immunotherapy in lung adenocarcinoma (LUAD) and glioblastoma. Cell adhesion signaling critically shapes tumor–microenvironment interactions, yet the upstream regulators coordinating these invasive programs at single-cell resolution remain incompletely understood. Methyltransferase Like protein 7B (METTL7B) has recently emerged as a candidate oncogenic regulator, but its lineage-specific functions and the potential downstream effectors are unclear. Methods: We integrated publicly available single-cell RNA sequencing datasets from LUAD and glioblastoma with The Cancer Genome Atlas (TCGA) transcriptomic analyses to resolve METTL7B-associated malignant cell states and microenvironmental interactions. Functional enrichment analyses identified invasion- and focal adhesion pathways linked to METTL7B expression. Gain- and loss-of-function experiments were conducted in LUAD and glioblastoma cell lines to validate downstream cell adhesion effectors. Spatial expression patterns were examined using immunofluorescence, and transwell assays were used to assess migratory and invasive phenotypes. Results: Single-cell analyses revealed that METTL7B was selectively enriched in malignant epithelial cells in LUAD and glioblastoma and defined a transcriptional program characterized by cell adhesion signaling. Integrin Alpha 3 (ITGA3) emerged as a conserved downstream effector of METTL7B, with progressive upregulation from minimally invasive to invasive LUAD and glioblastoma. Functional perturbation confirmed that METTL7B enhances tumor cell migration and invasion through integrin-associated pathways. Conclusions: METTL7B acts as a potential lineage-enriched regulator of invasive tumor states by activating cell adhesion signaling in LUAD and glioblastoma. These findings position METTL7B as a putative prognostic factor for strategies aimed at limiting invasion in lung cancer and glioblastoma.